Edgestream Partners, L.P. Eli Lilly & CO Transaction History

Edgestream Partners, L.P.

$2.23 Billion
Q3 2024

A detailed history of Edgestream Partners, L.P. transactions in Eli Lilly & CO stock. As of the latest transaction made, Edgestream Partners, L.P. holds 8,344 shares of LLY stock, worth $6.5 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

8,344

Previous 13,387 37.67%

Holding current value

$6.5 Million

Previous $12.1 Million 39.01%

% of portfolio

0.33%

Previous 0.59%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $3.89 Million - $4.84 Million	-5,043 Reduced 37.67%	8,344 $7.39 Million
Q2 2024 Aug 09, 2024	BUY	$724.87 - $909.04 $5.83 Million - $7.31 Million	8,039 Added 150.32%	13,387 $12.1 Million
Q1 2024 May 10, 2024	BUY	$592.2 - $792.28 $384,337 - $514,189	649 Added 13.81%	5,348 $4.16 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $1.28 Million - $1.51 Million	2,434 Added 107.46%	4,699 $2.74 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $4.07 Million - $5.61 Million	-9,361 Reduced 80.52%	2,265 $1.22 Million
Q2 2023 Aug 10, 2023	BUY	$350.74 - $468.98 $430,007 - $574,969	1,226 Added 11.79%	11,626 $5.45 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $1.55 Million - $1.82 Million	4,988 Added 92.17%	10,400 $3.57 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $650,817 - $758,332	2,024 Added 59.74%	5,412 $1.98 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $5.51 Million - $6.27 Million	-18,571 Reduced 84.57%	3,388 $1.1 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $704,350 - $827,011	-2,527 Reduced 10.32%	21,959 $7.12 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $4.6 Million - $5.71 Million	19,588 Added 399.92%	24,486 $7.01 Million
Q4 2021 Feb 15, 2022	SELL	$224.85 - $279.04 $8.92 Million - $11.1 Million	-39,692 Reduced 89.02%	4,898 $1.35 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $707,125 - $870,217	-3,191 Reduced 6.68%	44,590 $10.3 Million
Q2 2021 Aug 10, 2021	BUY	$180.55 - $233.54 $6.96 Million - $9 Million	38,536 Added 416.83%	47,781 $11 Million
Q1 2021 May 06, 2021	BUY	$164.32 - $212.72 $1.52 Million - $1.97 Million	9,245 New	9,245 $1.73 Million
Q4 2020 Feb 11, 2021	SELL	$130.46 - $172.63 $303,580 - $401,710	-2,327 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$146.22 - $169.13 $340,253 - $393,565	2,327 New	2,327 $344,000
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $4.19 Million - $5.19 Million	-39,224 Closed	0 $0
Q3 2019 Nov 08, 2019	SELL	$106.79 - $116.16 $13.5 Million - $14.7 Million	-126,674 Reduced 76.36%	39,224 $4.39 Million
Q2 2019 Aug 08, 2019	BUY	$110.79 - $129.32 $10.7 Million - $12.5 Million	96,684 Added 139.69%	165,898 $18.4 Million
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $7.7 Million - $9.07 Million	69,214 New	69,214 $8.98 Million
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $188,419 - $222,416	-2,539 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$81.94 - $87.89 $155,849 - $167,166	-1,902 Reduced 42.83%	2,539 $214,000
Q3 2017 Oct 30, 2017	BUY	$77.07 - $85.54 $342,267 - $379,883	4,441	4,441 $380,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Edgestream Partners, L.P. with notifications on news.

Account

Edgestream Partners, L.P. Eli Lilly & CO Transaction History